Recent Updates
Recently added Catalysts
ELUT Positive Sentiment Score: 75/100

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

Tuesday, April 22, 2025 1 min read
Key Takeaway: Elutia Inc. announced that its Chief Scientific Officer, Dr. Michelle LeRoux Williams, will participate in Chardan's Trending Issues in Drug Development Conference on April 29, 2025. The event will focus on regulatory catalysts and the evolving landscape of drug development. This participation highlights Elutia's efforts in drug-eluting biomatrix technologies aimed at improving medical device compatibility. A live webcast of the event will be available on Elutia's investor website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a reputable industry conference can enhance visibility.
  • Showcases Elutia's commitment to addressing evolving drug development challenges.
  • Opportunity for networking and collaboration with industry leaders.

Full Press Release Details

SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participate in Chardan’s Trending Issues in Drug Development Conference Series on Tuesday, April 29, 2025.
Chardan's Data & Regulatory Catalysts – Navigating an Evolving Landscape – Virtual
Format: Fireside Chat
Date and Time: Tuesday, April 29, 2025, 11:00 a.m. ET (8:00 a.m. PT)
A live and archived webcast of the fireside chat will be available in the “Investors” section of the Elutia website at http://investors.elutia.com/.
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
matt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.

Frequently Asked Questions

What is Elutia Inc. known for?

Elutia Inc. specializes in drug-eluting biomatrix technologies.

When is the Chardan conference featuring Elutia's CSO?

The Chardan conference takes place on April 29, 2025.

How can I watch the fireside chat from Elutia?

The fireside chat will be available in the Investors section of Elutia's website.

What is Elutia's mission?

Elutia aims to humanize medicine for patients needing implantable technologies.

Who is Elutia’s Chief Scientific Officer?

Michelle LeRoux Williams, Ph.D. is Elutia’s Chief Scientific Officer.

Tags: ELUT Viatris Investor Conferences Healthcare Elutia drug development biomatrix technologies medical devices Chardan
Last updated: Apr 22, 2025